(2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine

C27H33N13O — CID 134408593

IUPAC(2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine
SMILESCCN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nnc6ncc(-c7cnn(C)c7)nc65)C4)nc3)cn2)CC1
InChIInChI=1S/C27H33N13O/c1-3-37-6-4-22(5-7-37)39-16-20(12-32-39)19-10-29-27(30-11-19)38-8-9-41-23(17-38)18-40-26-25(34-35-40)28-14-24(33-26)21-13-31-36(2)15-21/h10-16,22-23H,3-9,17-18H2,1-2H3/t23-/m0/s1
InChIKeyNYOBWLXJORIKOS-QHCPKHFHSA-N
MW555.65 g/mol
LogP1.84
Rot. Bonds7

About (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine

(2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine (PubChem CID 134408593) has the molecular formula C27H33N13O and a molecular weight of 555.65 g/mol. Its IUPAC name is (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine.

Molecular Properties

Compound Name(2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine
PubChem CID134408593
Molecular FormulaC27H33N13O
Molecular Weight555.65 g/mol
Exact Mass555.29
IUPAC Name(2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine
SMILESCCN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nnc6ncc(-c7cnn(C)c7)nc65)C4)nc3)cn2)CC1
InChIInChI=1S/C27H33N13O/c1-3-37-6-4-22(5-7-37)39-16-20(12-32-39)19-10-29-27(30-11-19)38-8-9-41-23(17-38)18-40-26-25(34-35-40)28-14-24(33-26)21-13-31-36(2)15-21/h10-16,22-23H,3-9,17-18H2,1-2H3/t23-/m0/s1
InChIKeyNYOBWLXJORIKOS-QHCPKHFHSA-N
XLogP1.84
TPSA133.62 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500555.65
LogP ≤ 51.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Analyze (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine?
The IUPAC name of (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine (CID 134408593) is (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine.
What is the SMILES notation for (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine?
The canonical SMILES for (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine is CCN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nnc6ncc(-c7cnn(C)c7)nc65)C4)nc3)cn2)CC1.
What is the InChIKey of (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine?
The InChIKey is NYOBWLXJORIKOS-QHCPKHFHSA-N. The full InChI is InChI=1S/C27H33N13O/c1-3-37-6-4-22(5-7-37)39-16-20(12-32-39)19-10-29-27(30-11-19)38-8-9-41-23(17-38)18-40-26-25(34-35-40)28-14-24(33-26)21-13-31-36(2)15-21/h10-16,22-23H,3-9,17-18H2,1-2H3/t23-/m0/s1.
What are the key properties of (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine?
(2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine has a molecular weight of 555.65 g/mol, XLogP of 1.84, 7 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-4-[5-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine is sourced from PubChem (CID 134408593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).